Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novo Nordisk B | Copenhagen | Salute | Prodotti farmaceutici | 3,34 Bln DKK | 35,5x | 1,3 | 755,20 DKK | -0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 35% Rialzo | Fai l’upgrade a Pro+ | |
Coloplast | Copenhagen | Salute | Attrezzature e forniture medicali | 203,97 Mrd DKK | 40x | 34,7 | 913,60 DKK | 3,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 6% Rialzo | Fai l’upgrade a Pro+ | |
Genmab | Copenhagen | Salute | Ricerca medica e biotecnologica | 97,18 Mrd DKK | 21x | 1,5 | 1.531,50 DKK | -1,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Zealand Pharma | Copenhagen | Salute | Ricerca medica e biotecnologica | 57,75 Mrd DKK | -49x | 3,46 | 817 DKK | 0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 34,8% Rialzo | Fai l’upgrade a Pro+ | |
Demant | Copenhagen | Salute | Attrezzature e forniture medicali | 57,65 Mrd DKK | 24,2x | 0,44 | 264,80 DKK | 2,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 10,4% Rialzo | Fai l’upgrade a Pro+ | |
H Lundbeck AS | Copenhagen | Salute | Prodotti farmaceutici | 43,40 Mrd DKK | 15,9x | 3,6 | 37,10 DKK | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -3,5% Ribasso | Fai l’upgrade a Pro+ | |
H Lundbeck B | Copenhagen | Salute | Prodotti farmaceutici | 43,40 Mrd DKK | 15,9x | 3,6 | 45,56 DKK | 0,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 7,3% Rialzo | Fai l’upgrade a Pro+ | |
Alk Abello | Copenhagen | Salute | Prodotti farmaceutici | 36,94 Mrd DKK | 52,2x | 0,5 | 167,40 DKK | 4,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 7,2% Rialzo | Fai l’upgrade a Pro+ | |
Ambu B | Copenhagen | Salute | Attrezzature e forniture medicali | 32,66 Mrd DKK | 138,8x | 3,75 | 122,60 DKK | 3,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 11,6% Rialzo | Fai l’upgrade a Pro+ | |
Bavarian Nordic | Copenhagen | Salute | Prodotti farmaceutici | 16,09 Mrd DKK | 22,6x | -0,6 | 204,80 DKK | 2,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Embla Medical hf | Copenhagen | Salute | Attrezzature e forniture medicali | 14,99 Mrd DKK | 30,6x | 1,01 | 35,10 DKK | -0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 5,3% Rialzo | Fai l’upgrade a Pro+ | |
Chemometec | Copenhagen | Salute | Attrezzature e forniture medicali | 8,11 Mrd DKK | 59,5x | -2,61 | 465,80 DKK | -0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 16,6% Rialzo | Fai l’upgrade a Pro+ | |
Gubra AS | Copenhagen | Salute | Ricerca medica e biotecnologica | 7,80 Mrd DKK | -178,3x | 0,4 | 626 DKK | 31% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Bioporto | Copenhagen | Salute | Attrezzature e forniture medicali | 735,57 Mln DKK | -13,1x | -0,35 | 1,71 DKK | -3,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Scandinavian Medical Solutions AS | Copenhagen | Salute | Attrezzature e forniture medicali | 167,21 Mln DKK | 31x | -0,46 | 6 DKK | -1,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
ViroGates | Copenhagen | Salute | Ricerca medica e biotecnologica | 112,19 Mln DKK | -7,1x | 14,30 DKK | -23,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Bactiquant AS | Copenhagen | Salute | Attrezzature e forniture medicali | 102,45 Mln DKK | 4,10 DKK | -6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||||
Strategic Partners AS | Copenhagen | Salute | Ricerca medica e biotecnologica | 39,21 Mln DKK | -2,9x | -0,05 | 940 DKK | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Stenocare AS | Copenhagen | Salute | Prodotti farmaceutici | 25,97 Mln DKK | -1,4x | 1,25 DKK | -3,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |